Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 7 matching records.
7 results — page 1 of 1
- Level AMeta-analysisEurope PMC
Efficacy and safety of single versus repeated injections of mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 622 on Knee Osteoarthritis, Osteoarthritis, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 622
Stem Cell Res Ther - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level CProspective StudyEurope PMC
A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of an Autologous Blood Clot Product in the Treatment of Anal Fistula
Prospective Study with a reported sample of 33 on Autoimmune Research, published in Dis Colon Rectum (2024) — summary generated from the PubMed abstract.
- 2024
- n = 33
Dis Colon Rectum4 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level ARandomized Controlled TrialPubMed
Efficacy and safety of autologous adipose tissue-derived stromal vascular fraction in patients with thin endometrium: a protocol for a single-centre, longitudinal, prospective self-control study.
Randomized Controlled Trial with a reported sample of 308 on Hair & Scalp, published in BMJ Open (2022) — summary generated from the PubMed abstract.
- 2022
- n = 308
BMJ Open3 citations - Level BClinical TrialPubMed
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Clinical Trial with a reported sample of 17 on Neuroinflammation, published in Cell J (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Cell J7 citations - Level BRandomized Controlled TrialPubMed
Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.
Randomized Controlled Trial with a reported sample of 8 on Knee Osteoarthritis, Osteoarthritis, published in J Transl Med (2018) — summary generated from the PubMed abstract.
- 2018
- n = 8
J Transl Med
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406